Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Activated ras can protect kidney cells from a certain substance that causes cell death.

ARTS helps stop tumors by promoting cell death.

ITK inhibitors may effectively treat alopecia areata.

ATP helps prevent skin damage from vandetanib by reducing stress.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

CXCR2 in skin cells promotes tumor growth.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Akt2 protein is essential for normal cell division in early mouse embryos.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

XEDAR triggers a specific signaling pathway in cells.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

AKR1B10 enzyme may cause keloid scars and could be a treatment target.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Type II keratins are uniquely phosphorylated during stress and mitosis, affecting their structure and function.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

ERK activation spreads between cells, influencing cell division and wound healing.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Androgen receptors help prostate cancer cells grow and resist drugs.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.